From: Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions
90 day readmission or death (%) | 90 day readmission free survival (%) baseline impairment | Univariable odds ratio (95% CI) | ||||
---|---|---|---|---|---|---|
N | 3065 | 13388 | ||||
Age (median, IQR) | 74 | (62–83) | 69 | (55–79) | 1.20 (/10 years) | (1.17–1.23) |
Male sex | 1372 | (44.8) | 5770 | (43.1) ()) | 1.07 | (0.99–1.16) |
Residential care | 277 | (9.0) | 471 | (3.5) | 2.72 | (2.34–3.18) |
Deprived (highest quintile) | 298 | (9.7) | 1088 | (8.1) | 1.22 | (1.06–1.39) |
Rural (settlement <3000) | 735 | (24.0) | 3720 | (27.8) | 0.82 | (0.75–0.90) |
Admission context | ||||||
No admissions past yeara | 1896 | (61.9) | 10461 | (78.1) | 1.38 (/admission) | (1.34–1.43) |
1 admission past year | 593 | (19.3) | 1872 | (14.0) | ||
2 admissions past year | 244 | (8.0) | 620 | (4.6) | ||
3+ admissions past year | 332 | (10.8) | 435 | (3.2) | ||
Length of stay (median, IQR) | 7 | (2–16) | 3 | (1–9) | 1.05 (/7 days) | (1.04–1.06) |
Emergency admission | 2326 | (75.9) | 7760 | (58.0) | 2.28 | (2.09–2.50) |
Medical ward admission | 1889 | (61.6) | 6570 | (49.1) | 1.67 | (1.54–1.81) |
Intensive care admission | 98 | (3.2) | 366 | (2.7) | 1.18 | (0.94–1.47) |
Renal function | ||||||
No AKI | 2154 | (70.3) | 11676 | (87.2) | (reference group) | |
AKI stage 1 | 528 | (17.2) | 1190 | (8.9) | 2.41 | (2.15–2.69) |
AKI stage 2 | 233 | (7.6) | 341 | (2.5) | 3.70 | (3.12–4.40) |
AKI stage 3 | 150 | (4.9) | 181 | (1.4) | 4.49 | (3.60–5.60) |
No prior AKI episodesa | 2526 | (82.4) | 12188 | (91.0) | 1.71 (/episode) | (1.58–1.85) |
1 prior AKI episode | 414 | (13.5) | 1000 | (7.5) | ||
2+ prior AKI episodes | 125 | (4.1) | 200 | (1.5) | ||
Baseline eGFR (median, IQR)a | 63 | (48–83) | 66 | (52–87) | 0.94 (/10 ml/min/1.73 m2) | (0.93–0.96) |
Baseline eGFR 0–29 | 213 | (6.9) | 502 | (3.7) | ||
Baseline eGFR 30–44 | 423 | (13.8) | 1461 | (10.9) | ||
Baseline eGFR 45–59 | 713 | (23.3) | 3309 | (24.7) | ||
Baseline eGFR ≥60 | 1716 | (56.0) | 8116 | (60.6) | ||
Discharge creatinine 20% > baseline | 520 | (17.0) | 1167 | (8.7) | 2.14 | (1.91–2.39) |
Comorbidity | ||||||
Cancer | 410 | (13.4) | 973 | (7.3) | 1.97 | (1.74–2.23) |
Cardiac failure | 317 | (10.3) | 592 | (4.4) | 2.49 | (2.16–2.88) |
Cerebrovascular disease | 231 | (7.5) | 580 | (4.3) | 1.80 | (1.54–2.11) |
Dementia | 96 | (3.1) | 163 | (1.2) | 2.62 | (2.03–3.39) |
Diabetes | 336 | (11.0) | 776 | (5.8) | 2.00 | (1.75–2.29) |
Hemiplegia | 28 | (0.9) | 71 | (0.5) | 1.73 | (1.11–2.68) |
Liver disease | 59 | (1.9) | 156 | (1.2) | 1.66 | (1.23–2.25) |
Myocardial infarction | 257 | (8.4) | 638 | (4.8) | 1.83 | (1.57–2.13) |
Peptic ulcer disease | 81 | (2.6) | 278 | (2.1) | 1.28 | (1.00–1.64) |
Peripheral vascular disease | 162 | (5.3) | 452 | (3.4) | 1.60 | (1.33–1.92) |
Pulmonary disease | 346 | (11.3) | 704 | (5.3) | 2.29 | (2.00–2.62) |
Rheumatic disease | 82 | (2.7) | 289 | (2.2) | 1.25 | (0.97–1.60) |